Pfizer enters Cambodia
US-based pharma company Pfizer is about to enter the Cambodian market in a partnership with Switzerland’s DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia.
DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer.
DKSH says the new partnership will “further strengthen its market position in Southeast Asia while contributing incrementally to the group’s overall earnings and profitability over time.”
Earlier, DKSH Healthcare was appointed by Pfizer’s Thailand subsidiary as the sole nationwide distributor for all of its pharmaceutical products in Cambodia, effective at the beginning of 2013.
“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Cambodia so that more people will benefit from our healthcare innovations,” said Pichitchai Jak-paisan, finance director and Indochina general manager for Pfizer (Thailand).
He said Pfizer chose DKSH as it has a “well-established nationwide infrastructure in Cambodia, well-trained local staff and an in-depth understanding of the Cambodian market.”
The firm’s expertise in marketing and sales as well as its dedication to compliance and quality will also mean better services to Pfizer’s valued customers and business partners, he added.
US-based pharma company Pfizer is about to enter the Cambodian market in a partnership with Switzerland's DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia. DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer. DKSH says the new partnership will "further strengthen its market position in Southeast Asia while contributing incrementally to the group's overall earnings and profitability over time." Earlier, DKSH Healthcare was appointed by Pfizer's Thailand subsidiary as the sole nationwide distributor for all of...
US-based pharma company Pfizer is about to enter the Cambodian market in a partnership with Switzerland’s DKSH Group, a company focused on distribution and marketing of pharmaceutical products in Asia.
DKSH Business Unit Healthcare has said it has signed an agreement to provide marketing and sales, logistics, distribution, credit management and collection services in Cambodia for Pfizer.
DKSH says the new partnership will “further strengthen its market position in Southeast Asia while contributing incrementally to the group’s overall earnings and profitability over time.”
Earlier, DKSH Healthcare was appointed by Pfizer’s Thailand subsidiary as the sole nationwide distributor for all of its pharmaceutical products in Cambodia, effective at the beginning of 2013.
“We believe our partnership with DKSH will translate into wider and easier access to our high-quality medicines in Cambodia so that more people will benefit from our healthcare innovations,” said Pichitchai Jak-paisan, finance director and Indochina general manager for Pfizer (Thailand).
He said Pfizer chose DKSH as it has a “well-established nationwide infrastructure in Cambodia, well-trained local staff and an in-depth understanding of the Cambodian market.”
The firm’s expertise in marketing and sales as well as its dedication to compliance and quality will also mean better services to Pfizer’s valued customers and business partners, he added.
